Number of the records: 1
Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice
- 1.
SYSNO ASEP 0325250 Document Type C - Proceedings Paper (int. conf.) R&D Document Type Conference Paper Title Sinergistic therapeutic efffect of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin leads to significantly prolonged survival of mice Title Součinný léčebný efekt imunokomplexů IL-2/anti-IL-2 protilátky a Author(s) Tomala, Jakub (MBU-M) RID, ORCID
Kovář, Marek (MBU-M) RID, ORCID
Chmelová, Helena (MBU-M)
Strohalm, Jiří (UMCH-V)
Ulbrich, Karel (UMCH-V) RID
Říhová, Blanka (MBU-M) RIDSource Title Meeting of the International Society of Oncology and BioMarkers /36./. - Basel : KARGER, 2008 - ISSN 1010-4283 Pages s. 59-59 Number of pages 1 s. Action Meeting of the International Society of Oncology and BioMarkers /36./ Event date 05.10.2008-09.10.2008 VEvent location Tokyo Country JP - Japan Event type WRD Language eng - English Country CH - Switzerland Keywords doxorubicin ; IL-2/anti-IL-2mAb ; melanoma Subject RIV EC - Immunology R&D Projects GP301/07/P192 GA ČR - Czech Science Foundation (CSF) 1M0505 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) CEZ AV0Z50200510 - MBU-M (2005-2011) AV0Z40500505 - UMCH-V (2005-2011) UT WOS 000259724800097 Annotation Therapeutics sinergistic influence of IL-2/anti-IL-2 mAb complexes and polymer-bound doxorubicin lwas studied. A it nas been shown it leads to significantly prolonged survival of mice Workplace Institute of Microbiology Contact Eliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231 Year of Publishing 2009
Number of the records: 1